Cargando…
Identification of somatic copy number variations in plasma cell free DNA correlating with intrinsic resistances to EGFR targeted therapy in T790M negative non-small cell lung cancer
BACKGROUND: About 20–30% EGFR-mutant non-small lung cancer show intrinsic resistance to EGFR targeted therapies. Compared to T790M positive in acquired resistance patients, little is known about EGFR-TKI intrinsic resistance for T790M negative patients. METHODS: Thirty-one patients with advanced sta...
Autores principales: | Zhu, Lucheng, Liang, Jiafeng, Xia, Bing, Xu, Yasi, Qian, Ziliang, Ma, Shenglin, Zhang, Shirong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138977/ https://www.ncbi.nlm.nih.gov/pubmed/32274156 http://dx.doi.org/10.21037/jtd.2019.12.97 |
Ejemplares similares
-
Afatinib increases sensitivity to radiation in non-small cell lung cancer cells with acquired EGFR T790M mutation
por: Zhang, Shirong, et al.
Publicado: (2015) -
Epidermal growth factor receptor (EGFR) T790M mutation identified in plasma indicates failure sites and predicts clinical prognosis in non-small cell lung cancer progression during first-generation tyrosine kinase inhibitor therapy: a prospective observational study
por: Zhang, Shirong, et al.
Publicado: (2018) -
S-allylcysteine suppresses ovarian cancer cell proliferation by DNA methylation through DNMT1
por: Xu, Yasi, et al.
Publicado: (2018) -
Association between plasma somatic copy number variations and
response to immunotherapy in patients with programmed death-ligand 1-negative
non-small cell lung cancer
por: Zhang, Xiaochen, et al.
Publicado: (2022) -
SCNVSim: somatic copy number variation and structure variation simulator
por: Qin, Maochun, et al.
Publicado: (2015)